Cetera Investment Advisers’s BlackRock Health Sciences Trust BME Stock Holding History

Cetera Investment Advisers’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$509K	Sell	13,206 -12	-0.1%	-$495	﹤0.01%	3502
2025 Q4	$544K	Buy	13,218 +1,478	+13%	+$58.4K	﹤0.01%	3361
2025 Q3	$437K	Sell	11,740 -466	-4%	-$16.9K	﹤0.01%	3486
2025 Q2	$445K	Sell	12,206 -208	-2%	-$7.54K	﹤0.01%	3054
2025 Q1	$480K	Buy	12,414 +546	+5%	+$21.7K	﹤0.01%	2879
2024 Q4	$450K	Sell	11,868 -510	-4%	-$20.4K	﹤0.01%	2770
2024 Q3	$519K	Sell	12,378 -803	-6%	-$33.3K	﹤0.01%	2620
2024 Q2	$538K	Sell	13,181 -652	-5%	-$26K	﹤0.01%	2537
2024 Q1	$573K	Buy	+13,833	New	+$579K	﹤0.01%	2501

Other funds holding BME

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cetera Investment Advisers's BME Position: Q1 2026 in Review

Cetera Investment Advisers reduced its BlackRock Health Sciences Trust (BME) stake by 0.09% in Q1 2026, selling an estimated $495 and leaving 13,206 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #3502.

Cetera Investment Advisers first reported a position in BME in Q1 2024 and has held it in 9 quarters since. The position peaked at $573K in Q1 2024. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

Cetera Investment Advisers held 13,206 shares of BlackRock Health Sciences Trust worth $509K as of Q1 2026.
Cetera Investment Advisers sold 12 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $495.
BlackRock Health Sciences Trust made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3502 holding.
Cetera Investment Advisers first reported a position in BlackRock Health Sciences Trust in Q1 2024 and has held it in 9 quarters since.
Cetera Investment Advisers's BlackRock Health Sciences Trust position peaked at $573K in Q1 2024.
76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.